The Call for Committee Applications is Open AMCP Committees are vital to our mission and are essential in leading AMCP initiatives. Apply Now Close
  • 2022 Commitee Apps

    The Call for Committee Applications is Open

    Candidates interested in helping to advance AMCP's mission must submit their completed committee application by 5:30pm ET, Nov. 1, 2022.

    Apply Now

  • 2023 Corporate Membership Prospectus

    2023 Corporate Member Prospectus Now Available!

    Give your company a sharper edge in 2023. Start planning today.

    Learn More

  • Value-Based Care Lexicon

    Talking the Talk. In the World of Value-Based Care, Words Matter: A Lexicon for Value-Based Purchasing

    Explore the lexicon and additional value-based contracts resources in the AMCP Resource Center.

    Learn More

  • Major Depressive Disorder

    NEW: Major Depressive Disorder Resource Center

    Depression affects how you feel, think, and behave and can lead to a variety of emotional and physical problems. Find the latest therapies and research on our Major Depressive Disorder Resources page.

    Learn More

  • Nexus 2022

    Secure Your Spot at AMCP Nexus 2022 Today!

    Don’t miss your chance to attend Nexus 2022! Join more than 2,500 managed care leaders as we envision, ignite, and steer the future of public health — lowest rates available until July 20!

    Register Today

AMCP Summit

AMCP Summit on Addressing Health Disparities: Top 10 Takeaways

In June we conducted our inaugural AMCP Summit on Addressing Health Disparities. Enjoy 10 key takeaways from this virtual event.
By AMCP Staff 8/23/22

Disease State Resources

Get in-depth information and explore up-to-date resources about pressing disease states in AMCP’s Disease State Resource Center. AMCP is pleased to work with leading pharmaceutical companies to offer these timely resources to you.
3/9/22

Pharmacoequity: A New Opportunity for Managed Care Pharmacy

In this guest blog post, Tenicia Talley, PharmD, MSCR, discussespharmacoequity and how this applies to AMCP's efforts in addressing racial health disparities.
By Tenicia Talley, PharmD, MSCR 3/1/22
Icon - People Delivering Webinar on Computer - With White Background

Managed Care Decision-Makers

Looking for easy access to current product information, dossiers, and other resources to help you in formulary development? FormularyDecisions has the tools you need – all in one place!

Register Today
Icon - Person leaning on light bulb - with white behind

AMCP Foundation – Investing in the Future

AMCP Foundation supports managed care research and cultivates tomorrow's leaders. Join us to advance insights for a healthier future.

Learn More

Grow Your
Network through AMCP

8,000
Members waiting
for you to join them
As an AMCP member, you are connected to thousands of other members working for health plans, PBMs, and others who work to support and inform managed care pharmacy. Connect with fellow members today!
AMCP member
AMCP member
AMCP member
AMCP member
Join today and get started

The Latest

AMCP Logo

Nondiscrimination in Health Programs and Activities Proposed Rule...

On August 4, the Department of Health and Human Services released a Notice of Proposed Rulemaking on Nondiscrimination in Health Programs and Activities. In response, AMCP submitted comments on September 29 which applaud the Department's goal to reinstate regulatory protections from discrimination in covered health programs and activities.

9/29/22
AMCP Logo

The Value of RT-CGM to Support Achieving and Maintaining Glycemic...

A Science & Innovation webinar sponsored by Dexcom.

AMCP Logo

Humanistic and Economic Burden of Misdiagnosis of Bipolar I Disor...

A Science & Innovation webinar sponsored by Abbvie.

AMCP Logo

Think About Digital: Digital Therapeutics — Make a connection to ...

This sponsored webinar provides an overview of prescription digital therapeutics (PDTs) and their potential role in the future of MDD treatment. It will introduce PDTs based on the growth of the digital health landscape and the possible FDA pathways and requirements, speak to the potential value of PDTs in the MDD treatment landscape, and provide insight from payers on their current mindsets regarding PDTs.